Recruiting Lung Cancer Studies in Albany
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
The primary objective of this study is to describe the antitumor activity of tarlatamab in participants with small cell lung cancer (SCLC)....
About Lung Cancer Clinical Trials in Albany
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Albany, GA. These studies are seeking a combined 840 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Albany — FAQ
Are there lung cancer clinical trials in Albany?
Yes, there are 2 lung cancer clinical trials currently recruiting in Albany, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albany?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albany research site will contact you about next steps.
Are clinical trials in Albany free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albany studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Albany are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov